Home/Filings/4/0001209191-20-038680
4//SEC Filing

Michelon Francois Roger 4

Accession 0001209191-20-038680

CIK 0001681682other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 8:21 AM ET

Size

7.0 KB

Accession

0001209191-20-038680

Insider Transaction Report

Form 4
Period: 2020-06-23
Michelon Francois Roger
DirectorChief Executive Officer
Transactions
  • Exercise of In-Money

    Common Stock

    2020-06-23$0.87/sh+2,874$2,500163,610 total
  • Exercise of In-Money

    Warrants

    2020-06-232,8742,152 total
    Exercise: $0.87From: 2019-12-11Exp: 2024-12-11Common Stock (2,874 underlying)
Footnotes (1)
  • [F1]Includes unvested restricted stock units.

Issuer

ENDRA Life Sciences Inc.

CIK 0001681682

Entity typeother

Related Parties

1
  • filerCIK 0001691470

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 8:21 AM ET
Size
7.0 KB